Direkt zum Inhalt
Merck

SAB4200817

Sigma-Aldrich

Anti- Proteus vulgaris antibody produced in rabbit

IgG fraction of antiserum

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
12352203

Biologische Quelle

rabbit

Antikörperform

IgG fraction of antiserum

Klon

polyclonal

Beschreibung

Research area: Microbiome

Form

buffered aqueous solution

Mol-Gew.

~70 kDa

Speziesreaktivität

Proteus vulgaris

Verpackung

antibody small pack of 25 μL

Konzentration

~1 mg/mL

Methode(n)

immunoblotting: 1:20,000-1:40,000 using Proteus vulgaris LPS.
indirect ELISA: 1:20,000-1:40,000 using dead Proteus vulgaris bacteria for coating.

Versandbedingung

dry ice

Lagertemp.

−20°C

Posttranslationale Modifikation Target

unmodified

Allgemeine Beschreibung

Proteus vulgaris is a Gram negative rod-shaped bacteria, belongs to the Enterobacteriaceae family. Members of the genus Proteus (Proteus spp.) which also includes Proteus mirabilis, Proteus penneri and Proteus hauseri, originally characterize by their ability to swarm on solid surfaces, are widespread in the environment and the gastrointestinal tract of human and animals and known to be an opportunistic pathogens isolated from urine, wounds and other clinical sources. The Proteus spp. bacteria, are distinguished by their reactions for indole production, salicin fermentation and aesculin hydrolysis. P. vulgaris produces indole which differentiates it from the indole-negative P. mirabilis and P. penneri. Proteus spp. bacteria may also be found in soil or water habitats where they often regarded as indicators of fecal pollution and a contamination threat for potential water or seafood poisoning.

Immunogen

Proteus vulgaris dead OX19 bacteria: ATCC strain 6380

Anwendung

Anti-Proteus vulgaris antibody recognizes P. vulgaris whole extract and P. vulgaris LPS, the antibody also recognizes an additional ~70kDa band suspected as bacterial HSP70 (DNAK) in whole extract P. mirabilis, P. gingivalis, E.coli K-12, P.aeruginosa, S. flexneri, S. enterica and E. faecalis but it has no cross reactivity with P. mirabilis LPS. The antibody may be used in various immunochemical techniques including Immunoblotting and ELISA. 

Physikalische Form

Supplied as a solution in 0.01 M phosphate buffered saline pH 7.4, containing 15 mM sodium azide as a preservative.

Haftungsausschluss

This product is for R&D use only, not for drug, household, or other uses.

Lagerklassenschlüssel

10 - Combustible liquids

WGK

WGK 1

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

The effect of p-nitrophenylglycerol on swarming and the production of some virulence factors in Proteus vulgaris
Ghaidaa M, et al.
New York Science Journal, 6, 8-14 (2013)
C M O'Hara et al.
International journal of systematic and evolutionary microbiology, 50 Pt 5, 1869-1875 (2000-10-18)
Strains traditionally identified as Proteus vulgaris formed three biogroups. Biogroup 1, characterized by negative reactions for indole production, salicin fermentation and aesculin hydrolysis, is now known as Proteus penneri. Biogroup 2, characterized by positive reactions for indole, salicin and aesculin
ANTIMICROBIAL RESISTANCE PATTERNS OF PROTEUS ISOLATES FROM CLINICAL SPECIMENS
Bahashwan, et al.
EUROPEAN SCIENTIFIC JOURNAL, 9, 188-202 (2013)
Dominika Drzewiecka
Microbial ecology, 72(4), 741-758 (2016-10-27)
Proteus spp. bacteria were first described in 1885 by Gustav Hauser, who had revealed their feature of intensive swarming growth. Currently, the genus is divided into Proteus mirabilis, Proteus vulgaris, Proteus penneri, Proteus hauseri, and three unnamed genomospecies 4, 5
N Pal et al.
Annals of medical and health sciences research, 6(5), 267-273 (2017-05-16)
Proteus species cause a variety of community- and hospital-acquired illnesses. Synthesis of β-lactamases is the predominant mechanism for resistance to β-lactam antibiotics. Among the β-lactamases, extended spectrum β-lactamases (ESBLs) and AmpC β-lactamases are the most common. The objective of this

Fragen

Bewertungen

Kein Beurteilungswert

Aktive Filter

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.